MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Olfactory dysfunction"

  • 2017 International Congress

    A new aroma in the new world

    H. Fajardo, A. Medina, P. Gomez, r. Medina (tegucigalpa, Honduras)

    Objective: Investigate if olfactory impairment in PD patients  are related with other non motor symptoms Background: Non motor symptoms (NMS) can precede Parkinson's Disease (PD)…
  • 2017 International Congress

    Deep Brain Stimulation and Olfactory Function in Parkinson’s Disease

    O. Saatci, B. Polat, N. Helvaci Yilmaz, T. Zirh (Istanbul, Turkey)

    Objective: To evaluate the olfactory functions in the preoperative and postoperative period in Parkinson's Disease (PD) patients who underwent deep brain stimulation (DBS) of bilateral subthalamic nucleus (STN)…
  • 2016 International Congress

    Hyposmia as a predictor of non-motor symptom in patients with de novo Parkinson’s disease

    M. Sanoeva, N. Mansurova, A. Prokhorova (Bukhara, Uzbekistan)

    Objective: To evaluate hyposmia as a predictor of non-motor features in patients with early Parkinson's disease (PD). Background: Hyposmia is quite a common finding in…
  • 2016 International Congress

    Parkinson’s disease characteristics in patients with Gaucher’s disease

    A. Thaler, A. Mirelman, E. Shimoni, M. Victor, O. Assais, M. Grumberg, T. Gurevich, T. Shiner, M. Gana Weisz, A. Orr Urtreger, N. Giladi (Tel-Aviv, Israel)

    Objective: To assess the phenotype of Parkinson's disease (PD) patients in homozygote or compound heterozygote carriers of mutations in the β-glucocerebrosidase gene (GBA). Background: Gaucher's…
  • 2016 International Congress

    Olfactory loss – early non-motor symptom in Parkinson’s disease

    A. Kadirova, K. Mirzaeva, G. Rakhimbaeva (Tashkent, Uzbekistan)

    Objective: Recent longitudinal studies suggest that olfactory impairments can develop at early stage in Parkinson's disease (PD). Estimation of olfactory function is noninvasive examination method,…
  • 2016 International Congress

    Olfaction and gray matter volume in Parkinson’s disease. A voxel-based morphometry study

    K. Witt, N. Schmidt, O. Granert, L. Paschen, S. Wolff, G. Deuschl (Kiel, Germany)

    Objective: To evaluate the relation between olfactory functioning and gray matter (GM) volume in patients with Parkinson's disease (PD). Background: Olfactory impairment is one of…
  • 2016 International Congress

    The combined effect of REM sleep behavior disorder and hyposmia on cognition and motor phenotype in Parkinson’s disease

    S.B. Koh, S.H. Kang, H.M. Lee, W.K. Seo, J.H. Kim (Seoul, Korea)

    Objective: We investigated the relationship between olfactory impairment, REM sleep behavior disorders (RBD), initial cognitive performance and motor phenotype in Parkinson's disease (PD). Background: Olfactory…
  • 2016 International Congress

    Gustatory function of patients with essential tremor and its correlation with olfactory and cognitive functions

    M.G. Senol, H. Tekeli, M. Saglam, E. Arslanoglu (Istanbul, Turkey)

    Objective: We aimed to evaluate gustatory, olfactory and cognitive functions in Essential Tremor patients. Background: Essential tremor (ET) is a pathologically heterogeneous neurodegenerative disorder with…
  • 2016 International Congress

    Could smell test differ from scans without evidence of dopaminergic deficit and Parkinson’s disease?

    S.J. Kang, J.Y. Ahn, H.T. Kim (Seoul, Korea)

    Objective: To investigate the differences and similarities between SWEDD patients and PD patients using smell test. Background: The concept of SWEDD(scans without evidence of dopaminergic…
  • 2016 International Congress

    Olfaction analysis in spinocerebellar ataxia type 10 and type 3 comparing with healthy controls and PD

    M. Moscovich, A. Moro, R. Munhoz, H.G. Teive, L.S. Moryiama (Curitiba, Brazil)

    Objective: To Analyse olfaction in spinocerebellar ataxia type 10 and type 3. Background: The main clinical manifestations of spinocerebellar ataxias (SCA) result from the involvement…
  • « Previous Page
  • 1
  • …
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley